United States· US:67457-473_271feb8b-14b0-4818-b877-6e8df61b57b3
Tobramycin
A medicinal product containing tobramycin sulfate, registered in United States by Mylan Institutional LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TOBRAMYCIN SULFATE
- Manufacturer
- Mylan Institutional LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1167457-473-22
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tobramycin sulfate in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandBramitobChiesi Farmaceutici S.p.A.
- United KingdomBramitob 300mg/4ml nebuliser solution 4ml ampoulesChiesi Ltd
- SpainBRAMITOB 300 mg/4 ml SOLUCION PARA INHALACION POR NEBULIZADORChiesi España S.A.U.
- GermanyBramitobChiesi Gmbh
- SwedenBramitob 300 mg Lösning för nebulisatorChiesi Farmaceutici S.p.A.
- FinlandNebcinaEli Lilly Finland Oy Ab
- NetherlandsBramitob, verneveloplossing 300 mg/4 mlChiesi Pharmaceuticals B.V.
- CanadaSANDOZ TOBRAMYCINSANDOZ CANADA INCORPORATED
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Bramitob, Tobi
- Belgium · Obracin, Tobi
- Bulgaria · Tобрекс, Тобрамизил
- Cyprus · Bramitob, Ikobel
- Czechia · Bramitob, Tobramycin Vioser
- Germany · Bramitob, Gernebcin
- Denmark · Nebcina, Tobi
- Estonia · Tobramycin Via Pharma, Tobrex
- Spain · Bramitob, Tobrabact
- Finland · Tobi
- France · Nebcine, Tobi
- United Kingdom (Northern Ireland) · Bramitob, Munuza
- Greece · Bramitob, Eyetobrin
- Croatia · Bramitob, Tobrex
- Hungary · Bramitob, Brulamycin
- Ireland · Bramitob, Tobi
- Iceland · Tobi Podhaler, Vantobra
- Italy · Bramicil, Bramitob
- Liechtenstein · Tobi Podhaler, Vantobra
- Lithuania · Bramitob, Tobramycin Via Pharma
- Luxembourg · Obracin, Tobi
- Latvia · Bramitob, Tobramycin Via Pharma
- Malta · Tobi, Tobrex
- Netherlands · Bramitob, Obracin
- Norway · Bramitob, Nebcina
- Poland · Bramitob, Tobramycin Via Pharma
- Portugal · Bramitob, Tobi
- Romania · Tobi, Tobramicină Sun
- Sweden · Bramitob, Nebcina
- Slovenia · Tobrex
- Slovakia · Bramitob, Tobrex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e66e14fa-cda8-4f5d-a10d-c9442ee245e8 GET /v1/drugs/e66e14fa-cda8-4f5d-a10d-c9442ee245e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR; INTRAVENOUS",
"source": "ndc",
"strength": "40",
"substance": "TOBRAMYCIN SULFATE",
"productndc": "67457-473",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA065407",
"marketing_category": "ANDA"
}See everything about tobramycin sulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.